ABBV-461

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameABBV-461
Drug Alias NameABBV-461
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalifornia Institute For Biomedical ResearchAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalifornia Institute For Biomedical Research
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A